Products - Respiratory infections | Topic | NICE

Showing 4 products

Date | Title

Guidance programme: Technology appraisal guidanceRemove ‘Guidance programme: Technology appraisal guidance’ filter

Camlipixant for treating refractory or unexplained chronic cough [ID6722]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Gefapixant for treating refractory or unexplained chronic cough (terminated appraisal) (TA969)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
30 April 2024
Isavuconazol for treating invasive aspergillosis or mucormycosis in people 1 to 17 years [TSID12284]
Status:
Topic prioritisation
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Nitazoxanide for treating the common cold in people 12 years and over [ID4049]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC